What Is Heart Failure Caused by Coronary Artery Blockage?
Ischemic heart failure is a condition that arises when narrowing or blockage in the coronary arteries prevents adequate blood and oxygen from reaching the heart muscle over a prolonged period, weakening the heart's pumping function. It typically develops on the basis of prior heart attacks, long-standing coronary artery disease, or recurrent episodes of ischemia.
Why Is the Heart's Pumping Performance Affected?
When the heart muscle does not receive adequate blood flow, it weakens over time and loses its contractile strength. This can lead to a reduction in the amount of blood the heart pumps to the body (ejection fraction). This weakening of the heart directly affects a person's capacity to carry out daily activities.
Symptoms Seen in These Patients
Patients with ischemic heart failure often experience a marked decline in exercise capacity, early fatigue, shortness of breath with exertion or sometimes even at rest, swelling in the ankles, and an overall decline in quality of life. The severity of symptoms can vary depending on the degree of reduction in the heart's pumping performance.
Why Has EECP Been Studied in Ischemic Heart Failure?
EECP (Enhanced External Counterpulsation) is an FDA-cleared treatment method that uses cuffs wrapped around the legs, which inflate and deflate in sync with the heartbeat, aiming to increase blood flow to the coronary circulation during the heart's resting phase and reduce the heart's workload. Because of this mechanism, its effects on exercise capacity and symptoms in selected patients with ischemic heart failure have been the subject of clinical research.
The PEECH Study: What Does the Clinical Evidence Show?
The PEECH (Prospective Evaluation of EECP in Heart Failure) study is a randomized trial investigating the effect of EECP in patients with NYHA class II-III heart failure. The study reported significant improvement in exercise duration and time to exercise intolerance in the group receiving EECP compared to the control group, as well as favorable changes in quality-of-life measures. This is a single clinical study, and its findings apply to selected patient groups.
What We Do Not Claim About EECP
Current scientific evidence is limited, and it cannot be said that EECP strengthens the heart, definitively reduces hospitalization, or cures heart failure in every patient. EECP is not a substitute for standard heart failure treatment (medication, and device-based or interventional treatments when needed); in selected patients, it may be considered as a complementary option following evaluation by the cardiology team.
Does It Replace Standard Heart Failure Treatment?
No. The foundation of ischemic heart failure treatment is medication, lifestyle adjustments, and interventional or device-based treatments when needed. EECP is considered as an additional option in suitable patients whose exercise capacity remains low and whose symptoms persist despite these treatments. Whether it is right for you can only be decided after a comprehensive cardiology evaluation.
Source: Feldman AM, et al. "Enhanced External Counterpulsation Improves Exercise Tolerance in Patients With Chronic Heart Failure." Journal of the American College of Cardiology, 2006; 48(6):1198-1205. PMID: 16979005. Also, for study design: Feldman AM, et al. "Treating Heart Failure With Enhanced External Counterpulsation (EECP): Design of the Prospective Evaluation of EECP in Heart Failure (PEECH) Trial." Journal of Cardiac Failure, 2005. PMID: 15812754.
Note: This content is for general informational purposes only and is not a substitute for medical advice; EECP does not replace standard heart failure treatment and is a complementary option.
Find Out If EECP Is Right for You
Contact us now for a free initial assessment, or fill out our short test.